Top 10 Most Common Infectious Diseases in Nigeria (2026)

Drug abuse in Nigeria’s health ecosystem intersects with infectious diseases in ways that are often underappreciated. When Nigerians self-medicate or misuse pharmaceuticals in the face of infectious disease, treatment outcomes worsen, and resistance spreads. Understanding which diseases are most prevalent is the starting point for building a more rational and effective response.

The Infectious Disease Burden in Nigeria

Why Common Diseases in Nigeria Demand Attention

Nigeria carries one of the heaviest infectious disease burdens globally. Geography, climate, population density, limited healthcare access, and water and sanitation challenges all combine to sustain high rates of both endemic and epidemic diseases.

Addressing these diseases requires accurate diagnosis, appropriate treatment, and crucially, the preservation of effective medicines through proper stewardship.

Top 10 Most Common Infectious Diseases in Nigeria (2026)

1. Malaria

Malaria remains the leading cause of outpatient visits in Nigeria. It disproportionately affects children under five and pregnant women. Nigeria accounts for approximately 27% of all global malaria cases, making it the country with the highest malaria burden worldwide.

2. Tuberculosis (TB)

Nigeria is among the top high TB burden countries globally. Drug-resistant TB, including multidrug-resistant TB (MDR-TB), is an increasing concern. Health problems in Nigeria from TB are compounded by the country’s high HIV co-infection rates.

3. HIV/AIDS

Nigeria has the second-largest HIV epidemic in the world. While antiretroviral coverage has improved significantly, stigma, treatment interruptions, and drug resistance remain ongoing challenges. Infectious diseases in Nigeria like HIV interact with other conditions, increasing susceptibility to opportunistic infections.

4. Typhoid Fever

Typhoid fever is endemic across Nigeria, particularly in areas with limited access to clean water. Antibiotic resistance in Salmonella typhi strains is growing, with some isolates showing resistance to multiple first-line antibiotics.

5. Cholera

Cholera causes annual outbreaks in Nigeria, concentrated in flood-prone and conflict-affected states. It is entirely preventable through clean water and sanitation but remains a recurring emergency due to infrastructure gaps.

6. Lassa Fever

Lassa fever is endemic in several Nigerian states, particularly Edo, Ondo, and Ebonyi. It causes significant mortality, particularly in healthcare workers and pregnant women. Nigeria reports the majority of global Lassa fever cases each year.

7. Meningitis

The meningitis belt crosses northern Nigeria, where serogroup A and W meningococcal meningitis outbreaks occur seasonally. Pneumococcal and Hib meningitis also affect children nationwide.

8. Hepatitis B

Chronic hepatitis B infection affects a large proportion of Nigerian adults. Vertical transmission from mother to child remains a major route of infection. Vaccination has improved coverage but chronic disease in older Nigerians remains widespread.

9. COVID-19 and Respiratory Viruses

COVID-19 reshaped Nigeria’s healthcare landscape. Respiratory viral infections continue to circulate in 2026, though with reduced mortality compared to the pandemic peak. The legacy of COVID-19 includes increased awareness of infection prevention measures.

10. Diarrhoeal Diseases

Diarrhoeal diseases, including rotavirus, E. coli, and other enteric infections, remain a leading cause of child mortality in Nigeria. Most diarrhoeal illnesses are viral or caused by food contamination and do not require antibiotics, yet antibiotics are frequently prescribed for them inappropriately.

The Link Between Common Diseases and Antibiotic Resistance

Why Appropriate Treatment Matters for Each Disease

For each of these common diseases in Nigeria, the appropriate treatment differs. Malaria requires antimalarial drugs. HIV requires antiretrovirals. Most diarrhoeal diseases require oral rehydration. Prescribing antibiotics for viral or parasitic conditions only accelerates the resistance crisis.

NNAST (https://nnast.org/) works to strengthen Nigeria’s diagnostic capacity and clinical guidelines to ensure that each infectious disease Nigeria faces is met with the right treatment, not the most convenient one.

Frequently Asked Questions

Which disease kills the most Nigerians each year?

Malaria, neonatal disorders, and lower respiratory infections collectively account for the largest share of deaths in Nigeria. Malaria alone contributes to a substantial portion of under-five mortality. Drug resistance threatens to worsen outcomes for all of these conditions.

Are there vaccines available in Nigeria for any of these diseases?

Yes. Vaccines exist for meningitis, hepatitis B, cholera, rotavirus, and COVID-19. Malaria vaccines are also being rolled out in some African countries and may reach Nigeria at scale. Immunisation remains one of the most effective tools against infectious diseases.

What is the connection between infectious diseases in Nigeria and antibiotic resistance?

The misuse of antibiotics to treat non-bacterial conditions drives resistance in bacteria responsible for genuine bacterial infections. The inappropriate antibiotic treatment of viral or parasitic diseases that are common in Nigeria undermines the effectiveness of antibiotics when they are genuinely needed.

Scroll to Top
akinsete-omobosola-1004-240x240-29843

Dr. Omobosola Akinsete is a dedicated physician and a key member of the Nigerian Antimicrobial Stewardship Taskforce. She has been an internal medicine and adult Infectious Disease physician in the United States of America for 30  years . She graduated from Medical school at the University of Lagos, and has a masters in Public Health from Johns Hopkins school of Public Health. 

She did her Internal Medicine training at a Brown University hospital and her fellowship in Infectious Diseases  at the University of Minnesota where she is an associate professor. She has worked with the National Institutes of Health and Howard University a a coordinator for the Human Genome Project among other projects, she is a frequent public speaker and contributor to different types of media. She loves to advocate for healthcare in minority populations. She  has a lot of experience with  patients and health care providers on antimicrobial stewardship in her institution  HealthPartners in Minnesota U.S.A. Her expertise in the field of Infectious diseases and antimicrobial stewardship and her passion to improve health care in her home country will contribute significantly to the fight against antimicrobial resistance in Nigeria. Dr. Akinsete’s work with the taskforce focuses on leadership of the taskforce as chairperson and national coordinator, working closely with NCDC leadership, the Nigerian Federal Ministry of Health, stakeholders, and funding partners, and helping with capacity building of standardized antimicrobial stewardship and infectious disease educational programs. She will also use her expertise to guide providers and HealthCare institutions  on the ground . Her commitment to improving antimicrobial use and patient safety is invaluable to the nation’s public health efforts.